CMS Open Payments · Program Year 2024
Maquet Cardiopulmonary GmbH
Maquet Cardiopulmonary GmbH reported $205,735.00 across General Payments, Research, and Ownership to 14 physicians and teaching hospitals across 14 transactions.
- $205.7K Below-median payer
- All-tracks total
- 14 Below-median volume
- Transactions
- 14 Below-median reach
- Recipients
- #991
- of 1,925 companies
Maquet Cardiopulmonary GmbH reported $205,735.00 across all CMS Open Payments tracks (General + Research + Ownership) to 14 physicians and teaching hospitals in Program Year 2024 - ranking #991 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $205,735.00, averaging $14.7K per recipient.
Maquet Cardiopulmonary GmbH's payment reach score
Each tracked dimension is percentile-scored against the national companies corpus, then averaged across only the dimensions that apply to this company, a neutral scale measure of reporting activity, not a rating of quality, safety, or ethics.
Overall reach score
F
14/100
Total payments
F
12/100
Transaction volume
F
10/100
Physician reach
F
10/100
Payment type diversity
F
23/100
Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.
CMS Sunshine Act warrant
Manufacturer maquet-cardiopulmonary-gmbh Maquet Cardiopulmonary GmbH
$205.7K · #991/1,925 · 0.0% industry · PY2024
- TOT $205.7K
- RANK #991
- SHARE 0.0%
- TXN 14
- RCP 14
- CAT 2
- GEN $205.7K
- TOP1 98.8%
- PY 2024
Volume peers
Nearest volume peer: ITF Therapeutics LLC ($205.4K)
Maquet Cardiopulmonary GmbH sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →
What the Data Shows for Maquet Cardiopulmonary GmbH
The all-tracks total above combines three CMS reporting categories - General Payments, Research Payments, and Ownership/Investment interests - not one undifferentiated figure. For Maquet Cardiopulmonary GmbH that figure is drawn almost entirely from the General Payments track (day-to-day consulting, meals, travel and speaking fees). CMS publishes each Program Year's data roughly 12 months after the reporting period ends, so this reflects the most recently released cycle; see our methodology for how the tracks are standardized and compared across companies.
The 2-category breakdown below covers general payments only (see our methodology for how research and ownership payments are reported separately). The largest general-payment category is "Royalty or License" at $203.4K, accounting for 98.8% of this company's General Payments and 13 transactions.
General Payment Breakdown by Type
"Royalty or License" leads Maquet Cardiopulmonary GmbH's 2-category general-payment breakdown at $203.4K, 98.8% of the reported total.
How Maquet Cardiopulmonary GmbH divides its payments
Top payment categories by total reported dollar volume
| Payment Type | Amount | Transactions | % of Total |
|---|---|---|---|
| Royalty or License | $203.4K | 13 | 98.8% |
| Consulting Fee | $2.4K | 1 | 1.2% |
Recipient Concentration in General Payments
The five largest recipient relationships account for $205,735.00 (100.0%) of $205,735.00 in this company's General Payments records across 2 recipients.
General Payments scope note
Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.
Largest General-Payment relationships for Maquet Cardiopulmonary GmbH
The five named recipients with the highest reported General Payments from this company
- 1
The University Of Texas Medical Br.
$203,365.00 across 13 reported transactions
- 2
Caroline Ozment
$2,370.00 across 1 reported transactions
Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.
Spend vs. Concentration
Maquet Cardiopulmonary GmbH ranks #991 of 1,925 by total payments (bottom 49% by spend) but is notably more concentrated than that alone would suggest -- #144 of 1,838 by HHI (top 8% most concentrated). Its payments land on an unusually narrow set of recipients for its spend size.
View all 12 companies in this HHI neighborhood as a list
- BrioHealth Solutions, Inc. : $392.9K total payments, HHI 9908
- Synaptic Medical Corporation : $89.1K total payments, HHI 9906
- Epimed International, Inc : $506.9K total payments, HHI 9897
- Talis Clinical LLC : $150.9K total payments, HHI 9884
- Ortho Technology, Inc : $4.7K total payments, HHI 9876
- North American Rescue, LLC : $14.6K total payments, HHI 9810
- Maquet Cardiopulmonary GmbH (this company) : $205.7K total payments, HHI 9772
- Cardio Flow, Inc. : $101.7K total payments, HHI 9761
- Surgical Planning Associates, Inc. : $36.8K total payments, HHI 9732
- Clinical Technology, Inc : $36.5K total payments, HHI 9705
- BrainScope Company, Inc. : $95.9K total payments, HHI 9696
- Cardinal Health Inc : $62.6K total payments, HHI 9636
Similarly Concentrated Companies
Companies whose General Payments are spread across recipients about as (un)evenly as Maquet Cardiopulmonary GmbH's, measured by the same HHI concentration index above, not by payment size.
What HHI 2,500 means here
2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about Maquet Cardiopulmonary GmbH.
Companies with Similar Payment Volumes
Open a profile or compare a similar company's CMS-reported payment pattern with Maquet Cardiopulmonary GmbH.
Showing 6 of 1,924 companies with CMS-reported payment data.
Polarean, Inc.
Austin Medical Ventures Inc
OCULUS, Inc.
Synapse Biomedical Inc
TruAbutment Inc.
Put this to use
Maquet Cardiopulmonary GmbH ranks #991 of 1,925 by all-tracks total payments, led by "Royalty or License".
- See how manufacturer spending compares across the full leaderboard. Top 100 by total payments
- Compare "Royalty or License" spend across every manufacturer, not just Maquet Cardiopulmonary GmbH. Payment type breakdowns
- New to Open Payments? Learn what these figures do and do not show. Read the guide
Reported payments reflect what companies disclosed to CMS; a payment is not evidence of wrongdoing.
Disclaimer
This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.